spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2018

BioTrinity 2018

23-25 April 2018
Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.

Each year we seek to improve and evolve the format of the conference in-line with industry trends and to meet the changing demands of our delegates, with key highlights including:

·        Over 2,000 private partnering meetings supported by the partneringONE™ booking system

·        Innovative and insightful programme of keynote presentations, panel discussions and round table debates exploring the latest hot topics in the industry

·        BioLaunchPad™ - a single track series of Company Showcase presentations, all in one room, with an audience capacity of up to 200

·        An improved environment in the partnering area including additional lounge areas and branded coffee stands

·        Refined programme of networking events to further support collaboration and partnership opportunities between delegates.

Our theme for BioTrinity 2018 is ‘Next Generation Healthcare’ which we will explore via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘Fintech and the Future of the Investment Industry’ – more updates on speakers and topics will follow soon.

A general delegate ticket includes access to the whole conference, including the use of the partneringONE™ meeting scheduler, access to keynote and panel discussions, BioLaunchPad™ company showcase presentations, all social networking events and full catering throughout the conference.
Special rates are available to OBN Members, who can save up to £300 per delegate. Please contact our Membership Manager (Nicola Westgate – nicola.westgate@obn.org.uk) to find out if you are eligible for a member rate or to enquire about becoming an OBN Member. Please note that ticket prices increase in the run-up to the event – the earlier you book, the more money you save!

Please visit www.biotrinity.comfor up to date information.

Organiser contact details:

OBN Events Team
events@obn.org.uk

phone +44 (0) 1235 420 879
email events@obn.org.uk
web www.biotrinity.com
email Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR
 
Print this page
Send to a friend
   
spacer
Industry Events

4th Annual Formulation & Drug Delivery Congress

8-9 May 2018, London, UK

Oxford Global are proud to present our hugely popular 4th Annual Formulation & Drug Delivery Congress, 8th – 9th May 2018, London, UK.Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan Banner of T3_events_97 on Samedan Banner of BIO_Europe_Events_102 on Samedan

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>


News and Press Releases

York Health Economics Consortium offers an updated training event

Health economics evidence is a key element in much health services research and particularly in health technology assessments, including submissions for NICE single technology appraisals. Identifying economic evidence to inform submissions involves searches in a range of databases and uses a variety of strategies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement